Faculty of Health Sciences
School of Medicine
Department of Medical Oncology
Research articles in refereed specialist journals
Journal Title
Vorobiof DA, Rapoport BL, Chasen MR, Slabber CF, McMichael GB, Eek RW, Mohammed C: 2004. First line therapy with paclitaxel (Taxol) and pegylated liposomal doxorubicin (Caelyx) in patients with metastatic breast cancer: A multicentre phase II study. Breast, 13, pp 219-226.
de Wit R, Herrstedt J, Rapoport BL, Carides AD, Guoguang-Ma J, Elmer M, Schmidt C, Evans D, Horgan KJ: 2004. The oral NK[1] antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised placebo-controlled phase III clinical trials. European Journal of Cancer, 40, pp 403-410.
Wadler S, Levy D, Frederickson HL, Falkson CI, Wang Y, Weller EA, Burk R, Ho G, Kadish AS: 2004. Phase II trial of interleukin-12 in patients with advanced cervical cancer : Clinical and immunologic correlates Eastern Cooperative Oncology Group Study E1E96. Gynecologic Oncology, 92 (3), pp 957-964.
|
